If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
I really tried to make it a whole newsletter without mentioning 340B. I came close, but — alas — I can’t get away. If you want to search Cost Curve
One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
I really tried to make it a whole newsletter without mentioning 340B. I came close, but — alas — I can’t get away. If you want to search Cost Curve
One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
There is a ton of research in the journals that has hit over the past week or so. It all deserves some visibility and some thought. I’m a big fan
Nothing Found! Ready to publish your first post? Get started here.
Popular
Most Viewed
- CMS Patient-Focused Listening Session Transcripts (1,473)
- Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (892)
- More IRA Lawsuits Coming, PhRMA Chief Predicts (719)
- Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (687)
- Looking Under the Hood at the Pricing Approach for the New Zepbound Obesity Med (643)
Archives
- December 2024 (7)
- November 2024 (17)
- October 2024 (19)
- September 2024 (19)
- August 2024 (17)
- July 2024 (18)
- June 2024 (15)
- May 2024 (17)
- April 2024 (21)
- March 2024 (18)
- February 2024 (18)
- January 2024 (18)
- December 2023 (18)
- November 2023 (16)
- October 2023 (21)
- September 2023 (6)
